Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul R Buckley

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Immunotherapy Advances|April 21, 2023
A systems approach evaluating the impact of SARS-CoV-2 variant of concern mutations on CD8+ T cell responsesPaul R Buckley, Chloe H Lee, Agne Antanaviciute, et al.
Frontiers in Immunology|November 30, 2020
Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus StrainsChloe H Lee, Mariana Pereira Pinho, Paul R Buckley, et al.
Immunology|February 10, 2022
HLA-dependent variation in SARS-CoV-2 CD8 <sup>+</sup> T cell cross-reactivity with human coronavirusesPaul R Buckley, Chloe H Lee, Mariana Pereira Pinho, et al.
Genome Medicine|September 13, 2023
A robust deep learning workflow to predict CD8 + T-cell epitopesChloe H Lee, Jaesung Huh, Paul R Buckley, et al.
Briefings in Bioinformatics|April 26, 2022
Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigensPaul R Buckley, Chloe H Lee, Ruichong Ma, et al.
Frontiers in Immunology|October 2, 2019
Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-ActionPaul R Buckley, Kieran Alden, Margherita Coccia, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Immunotherapy Advances|April 21, 2023
A systems approach evaluating the impact of SARS-CoV-2 variant of concern mutations on CD8+ T cell responsesPaul R Buckley, Chloe H Lee, Agne Antanaviciute, et al.
Frontiers in Immunology|November 30, 2020
Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus StrainsChloe H Lee, Mariana Pereira Pinho, Paul R Buckley, et al.
Immunology|February 10, 2022
HLA-dependent variation in SARS-CoV-2 CD8 <sup>+</sup> T cell cross-reactivity with human coronavirusesPaul R Buckley, Chloe H Lee, Mariana Pereira Pinho, et al.
Genome Medicine|September 13, 2023
A robust deep learning workflow to predict CD8 + T-cell epitopesChloe H Lee, Jaesung Huh, Paul R Buckley, et al.
Briefings in Bioinformatics|April 26, 2022
Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigensPaul R Buckley, Chloe H Lee, Ruichong Ma, et al.
Frontiers in Immunology|October 2, 2019
Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-ActionPaul R Buckley, Kieran Alden, Margherita Coccia, et al.
Pageof 1